lncRNA ACVR2B-AS1 modulates thyroid cancer progression by regulating miR-195-5p
lncRNA ACVR2B-AS1 shows potential as a prognostic marker in TC and may regulate tumor progression through the miR-195-5p/FGF2 axis, offering new insights for TC diagnosis and treatment.
Authors
- Huayi Zhang (ORCID: https://orcid.org/0009-0004-7874-8542)
- Lingli Hu (ORCID: https://orcid.org/0000-0002-7684-2613)
- Tianshi Qin (ORCID: https://orcid.org/0000-0002-2084-3537)
- Jun Yang (ORCID: https://orcid.org/0000-0002-9401-3528)
- Miaoyun Long (ORCID: https://orcid.org/0000-0003-4231-6938)
- Lei Chengqiang
- Haibo Xiao (ORCID: https://orcid.org/0009-0002-0520-0805)
- Qiong Luo (ORCID: https://orcid.org/0000-0001-8216-4524)
- Fang Chen
Institutions
- Hengyang Normal University (CN)
- Hunan Normal University (CN)
- Xiangyang Central Hospital (CN)
- Hengyang Academy of Agricultural Sciences (CN)
- Chongqing Dazu District People's Hospital (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1007/s12672-025-01993-7
- Citations
- 2
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 1.87